BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioSpecifics Technologies Corporation 

35 Wilbur Street

Lynbrook  New York  11563-2358  U.S.A.
Phone: 516-593-7000 Fax: 516-593-7010


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Suppliers

Segment
Pharmaceuticals





 Company News
BioSpecifics Technologies Corporation (BSTC) Announces Presentations At Upcoming Investor Conferences 9/3/2014 4:06:25 PM
Look Out Auxilium Pharmaceuticals (AUXL), BioSpecifics Technologies Corporation (BSTC) Also Touts Positive Data From Phase 2a Study Of CCH For Cellulite 8/22/2014 6:02:20 AM
BioSpecifics Technologies Corporation (BSTC) Reports Second Quarter 2014 Financial Results 8/12/2014 8:38:55 AM
BioSpecifics Technologies Corporation (BSTC) Announces Initiation Of Phase 2 Clinical Study Of CCH For Treatment Of Lipoma 8/8/2014 7:40:54 AM
BioSpecifics Technologies Corporation (BSTC) Announces Appointment Of Max Link, Ph.D. To Board Of Directors 8/5/2014 9:12:39 AM
BioSpecifics Technologies Corporation (BSTC) To Host Conference Call To Report Second Quarter 2014 Financial Results On Monday, August 11, 2014 8/4/2014 8:56:39 AM
BioSpecifics Technologies Corporation (BSTC) (NASDAQ: BSTC) To Ring The NASDAQ Stock Market Opening Bell 7/22/2014 3:43:06 PM
BioSpecifics Technologies Corporation (BSTC) To Be Added To Russell 3000® Index 6/27/2014 9:21:58 AM
BioSpecifics Technologies Corporation (BSTC) Announces Filing By Swedish Orphan Biovitrum For EU Approval Of XIAPEX For Peyronies Disease 6/26/2014 6:18:27 AM
BioSpecifics Technologies Corporation (BSTC) Announces New Analyses Of XIAFLEX For Peyronie's Disease Presented At American Urological Association 5/20/2014 6:26:41 AM
12345678910...